Publications of FA Anderer

Steinmassl, M.; Anderer, F.: Enhancement of human NK and LAK cytotoxicity against HCMV-infected cells by rhamnogalacturonan: specificity of reaction. Viral Immunology 9 (1), pp. 27 - 34 (1996)

Freiberg, B.; Puhlmann, C.; Anderer, F.: Human monoclonal antibody developed against a metastasizing paraganglioma: preparation and preclinical studies. Anticancer Research 15 (6B), pp. 2489 - 2493 (1995)

Klein-Franke, A.; Anderer, F.: IL-12-mediated activation of MHC-unrestricted cytotoxicity of human PBMC subpopulations: synergic action of a plant rhamnogalacturonan. Anticancer Research 15 (6B), pp. 2511 - 2516 (1995)

Hauer, J.; Voetsch, W.; Anderer, F.: Comparison of hexose acetate-specific receptors isolated from human leukocytes showing competitive inhibition of human CD56+NK and LAK cytotoxicity. Immunology Letters 48 (1), pp. 53 - 57 (1995)

Hoefer, M.; Anderer, F.: Anti-(transforming growth factor beta) antibodies with predefined specificity inhibit metastasis of highly tumorigenic human xenotransplants in nu/nu mice. Cancer Immunology, Immunotherapy 41 (5), pp. 302 - 308 (1995)

Puhlmann, C.; Anderer, F.: Optimizing production of human monoclonal IgG antibodies by in vitro-primed human PBMC: influence of CD56+ NK cell depletion. Hybridoma 14 (4), pp. 391 - 396 (1995)

Zhu, H.-G.; Voetsch, W.; Hauer, J.; Anderer, F.: Chemospecificity and cross-reactivity of target cell recognition by human CD56+ NK and LAK cells. Scandinavian Journal of Immunology 41 (6), pp. 545 - 552 (1995)

Puhlmann, C.; Freiberg, B.; Anderer, F.: Lack of expression of a 31/33kD surface protein on human colon carcinoma cells is a marker for metastasizing potential. Anticancer Research 14 (6B), pp. 2701 - 2707 (1994)

Steinmassl, M.; Anderer, F.: Structural specificity of MHC-unrestricted recognition of HCMV-infected target cells by human CD56+NK and LAK cells. Scandinavian Journal of Immunology 40 (6), pp. 665 - 668 (1994)

Hauer, J.; Voetsch, W.; Anderer, F.: Identification of a mannose-acetate-specific 87-kDa receptor responsible for human NK and LAK activity. Immunology Letters 42 (1-2), pp. 7 - 12 (1994)

Zhu, H.-G.; Zollner, T.; Klein-Franke, A.; Anderer, F.: Enhancement of MHC-unrestricted cytotoxic activity of human CD56+ CD3- natural killer (NK) cells and CD3+ T cells by rhamnogalacturonan: target cell specificity and activity against NK-insensitive targets. Journal of Cancer Research and Clinical Oncology 120 (7), pp. 383 - 388 (1994)

Zhu, H.-G.; Klein-Franke, A.; Anderer, F.: Signal requirement for induction of MHC-unrestricted antitumor cytotoxicity of human T cell CD4+/CD8+ subpopulations. Anticancer Research 14 (3A), pp. 953 - 961 (1994)

Zhu, H.-G.; Zollner, T.; Klein-Franke, A.; Anderer, F.: Activation of human monocyte/macrophage cytotoxicity by IL-2/IFN gamma is linked to increased expression of an antitumor receptor with specificity for acetylated mannose. Immunology Letters 38 (2), pp. 111 - 119 (1993)

Zollner, T.; Zhu, H.-G.; Anderer, F.: Induction of NK-like activity in T cells by IL-2/anti-CD3 is linked to expression of a new antitumour receptor with specificity for acetylated mannose. Anticancer Research 13 (4), pp. 923 - 930 (1993)

Hauer, J.; Anderer, F.: Mechanism of stimulation of human natural killer cytotoxicity by arabinogalactan from Larix occidentalis. Cancer Immunology, Immunotherapy 36 (4), pp. 237 - 244 (1993)

Reins, H.-A.; Steinhilber, G.; Freiberg, B.; Anderer, F.: Anti-epidermal growth factor receptor monoclonal antibodies affecting signal transduction. Journal of Cellular Biochemistry 51 (2), pp. 236 - 248 (1993)

Doelker, I.; Anderer, F.: The CySF-L2 factor from dialysable human leucocyte extract activates natural killer cytotoxicity by induction of interferon gamma. Cancer Immunology, Immunotherapy 34 (5), pp. 299 - 305 (1992)

Voetsch, W.; Anderer, F.: The ontogeny of bovine thymostimulin production in fetal and postnatal age. Thymus 20 (2), pp. 127 - 133 (1992)

Neidlinger, A.-C.; Anderer, F.: Dialysable factors from human leukocyte extracts activating human NK cytotoxicity against tumor cells: identification of factor-producing leukocyte subpopulations. Anticancer Research 11 (6), pp. 2023 - 2028 (1991)

Menrad, A.; Anderer, F.: Expression of LDL receptor on tumor cells induced by growth factors. Anticancer Research 11 (1), pp. 385 - 390 (1991)